← FDA Drug Approvals (Drugs@FDA)

TADALAFIL

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: AUROBINDO PHARMA LTD · Approved 2019-02-05

Drug application

FDA Application #

ANDA206286

Application type

Abbreviated New Drug Application (Generic)

Brand name

TADALAFIL

Generic name

TADALAFIL

Active ingredients

TADALAFIL

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

AUROBINDO PHARMA LTD

Manufacturer

Aurobindo Pharma Limited

First approval

2019-02-05

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown